SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-005075
Filing Date
2015-11-13
Accepted
2015-11-13 17:15:20
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT oxis_10q.htm 10-Q 516673
2 CERTIFICATION oxis_ex311.htm EX-31.1 12842
3 CERTIFICATION oxis_ex312.htm EX-31.2 14465
4 CERTIFICATION oxis_ex321.htm EX-32.1 6092
5 CERTIFICATION oxis_ex322.htm EX-32.2 6764
  Complete submission text file 0001354488-15-005075.txt   1909564

Data Files

Seq Description Document Type Size
6 oxis-20150930.xml EX-101.INS 269973
7 oxis-20150930.xsd EX-101.SCH 16883
8 oxis-20150930_cal.xml EX-101.CAL 32473
9 oxis-20150930_def.xml EX-101.DEF 34977
10 oxis-20150930_lab.xml EX-101.LAB 142272
11 oxis-20150930_pre.xml EX-101.PRE 104893
Mailing Address 4830 W KENNEDY BLVD SUITE 600 TAMPA FL 33609
Business Address 4830 W KENNEDY BLVD SUITE 600 TAMPA FL 33609 (800) 304-9888
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 151230166
SIC: 2834 Pharmaceutical Preparations